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ESCULENTOSIDE A (EsA) is a saponin isolated from
the roots of Phytolacca esculenta. Previous
experiments have shown that it has strong anti-
inflammatory effects. Tumour necrosis factor
(TNF) is a very important inflammatory mediator.
It is known that there are two types of TNF--
TNF is from macrophages/monocytes and TNF
is from activated lymphocytes. In order to study
the mechanism of the anti-inflammatory effect of
EsA, it was determined whether TNF production
from human peripheral monocytes was altered
by EsA under lipopolysaccharide (LPS)-stimulated
conditions. EsA was found to decrease TNF pro-
duction in a dose-dependent manner at con-
centrations higher than 1 mol/l EsA. Recent
studies have shown that EsA has a curative effect
on chocolate cyst and other inflammatory
diseases. Our previous studies have shown that
EsA could reduce the release of platelet activating
factor (PAF) from rat macrophages, and inhibit
interleukin-1 and interleukin-6 production from
routine macrophages. The reducing effects of EsA
on the release of TNF, IL-1, IL-6 and PAF may
explain its anti-inflammatory effect.
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Introduction
Esculentoside A (EsA) is a saponin isolated
from the root of Phytolacca esculenta, and is
identified as: 3-O[]3-D-glucopyranosyl-(1-4)-[-D-
xylo-pyranosylJ phytolaccagenin. The structure of
this compound is shown in Fig. 1. Experiments
have shown that it has strong anti-inflammatory
effects. It is now known that tumour necrosis
factor (TNF) possess a number of properties of
inflammatory response.2’3 Platelet activating factor
(PAF), interleukin-1 and interleukin-6 are also
inflammatory mediators. It has been shown that
EsA inhibited the production of PAF by A23187
stimulated rat macrophages,4’5 and the produc-
tion of TNFa, IL-1, IL-6 of LPS stimulated murine
peritoneal macrophages.<8 The aim of this work
was to evaluate the effects of EsA on the produc-
tion of TNFa by LPS stimulated human periph-
eral monocytes.
Materials and Methods
Reagent: RPMI-1640, lipopolysaccharide (Escher-
ichia coli 055:B5) and calcimycin (A23187)were
purchased from Sigma (USA).
Human peripheral monocyte preparation:
Human monocytes were isolated by a combina-
tion of Ficoll-Hypaque gradient centrifugati0n
and centrifugal elutriation. This procedure
yielded populations of monocytes with greater
than 95% purity. The cells were washed three
times in RPMI-1640 and suspended at 1 x 10
cells per 1 ml in freshly prepared standard
culture medium. The cells were plated at 1 ml of
cells per well.
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FIG. 1. The structure of esculentoside A.
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TNF production: Two hours later, the medium
containing non-adherent cells was decanted and
the non-adherent cells in supernatant were
counted to measure the adherence ratio. TNF0t
activity was expressed as U/10 monocytes. The
adherent cells were rinsed twice with Hanks’s
solution. Then the adherent cells were incubated
with Aisv (1 t.tmol/1) for 6 h. After incubation,
the medium was discarded, and the cells were
washed three times with RPMI-1640 to remove
Ai8r. Fresh culture medium without serum was
added to every well with lipopolysaccharide
(LPS, 10 lag/ml) in the presence or absence of
Table 1. Effect of esculentoside A on tumour
necrosis factor production from 10
6 human
peripheral monocyte stimulated by LPS 10 lg/ml,
mean -t-_ SD, n 3 samples
TNF activity (U/106)
LPS 51.4 +_ 4.6
LPS+EsA (lmol/I)
0.01 55.0 _+ 13.5
0.1 45.2 +_ 8.9
1.0 36.5 -t- 3.6*
10.0 27.1 -t- 6.1"
*p < 0.05 versus control group.
EsA. The cultures were incubated in a humidi- cells. One unit of TNFa was defined as the reci-
fied atmosphere of 5% CO2 and at 37C for procal of the dilution of a preparation that
another 6 h. The supernatants were harvested results in 50% survival of the cells. The results
and centrifuged. The cell-free supernatants were are presented in Table 1. It is observed that the
collected, dialysed in phosphate-buffer solution decrease of TNFa production was significant at
for 24h, and stored at-20C prior to activity the concentrations of I and 10 l.tmol/1 EsA.
assay.
Effects ofEsA on the kinetics ofTNF production
TNF production assay: TNFa assay was per- from human monocytes: Monocytes were cul-
formed essentially as described by Kunkel et al.5 tured in LPS (10 l.tg/ml) with or without EsA, and
with minor modifications. Briefly, L929 cells the supernatants were harvested at 2h intervals.
(50000/well) were dispensed into 96-well fiat- TNFa activity can be detected after 2 h exposure
bottomed microtitre plates in a volume of 0.1 to LPS. Figure 2 shows that TNFa production by
ml/well. The following day, the cells were incu- human monocytes were inhibited in a time
bated for 18 h in the presence of 1 l.tg of actino- dependent manner by EsA at a concentration of
mycin D and serial 1:2 dilutions of test sample. 5 I.tmol/1.
Media were then decanted, and the remaining
cells in each well were stained with crystal violet Ejects of Ex4 on cellular activi{y: In order to
for about 15 min, washed with tap water, and eliminate the possibility that EsA was toxic for
dried at 40C. Absorbance of the cells in each the cells tested, cell viability was monitored by
well was read using a microenzyme linked immu- measuring LDH activity in the supernatant and by
nosorbent autoreader. Units of TNF0t activity the trypan blue exclusion test performed at the
were defined as described by Kunkel et al.5 end of the macrophage culture. Results of the
Cell viability.. The trypan blue exclusion test was
performed after 6 h incubation with or without
EsA. Cell viability was also determined by mea-
suring lactate dehydrogenase (LDH) activity in
the cell-free suternatants according to the
method of Beutle.
Statistics: Each experiment was carried out at
least three times. Values were expressed as the
mean standard error. Variation between paral-
lel experiments was less than 30%. Probability
values for statistical differences were determined
by Student’s t-test and p values of less than 0.05
were considered significant.
Results
2 4
Time/h
LPS+EsA ] I.PS
Effects of Es on production of T]V]z from FIG. 2. Effect of EsA on the kinetics of TNF production in super-
natants from human peripheral monocytes stimulated with 10 htla?l f/onocyte$: TNF Jn the sueEnatant a[eE ig/ml LPS for 2, 4 and 6h. The concentration of EsA was 5
being dialysed was assessed by the killing of L929 l.tmol/I, n 3, mean SD, *p< 0.05 versus LPS.
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Table 2. LDH activities in supernatants and cell viability ratio of
human peripheral monocytes treated with or without esculento-
side A. n 3 samples, mean -t- SD
LDH activity (U/ml) Cell viability ratio (%)
Control 4.35 -I- 0.17 > 99
EsA (pmol/I)
0.01 4.47 --t-_ 0.19 >99
0.1 4.29 -i- 0.14 >99
1.0 4.55 +_ 0.16 > 99
10.0 4.44 ___
0.35 > 99
LDH in supernatant of adherent macrophages,
cultured for 6h with various concentrations of
EsA, was not different from that of the control,
as is shown in Table 2. Cell viability was con-
firmed by the trypan blue exclusion test. The cell
viability ratio in test samples was more than 99%
(Table 2). The result was the same as previously
reported.
Discussion
In this study, EsA induced a dose-dependent
decrease in the TNFa concentrations measured
in the supernatant of LPS-stimulated human
monocytes. The kinetics of TNFa production
were also changed. TNF was initially identified as
a factor that appeared in the circulation of
animals following the injection of endotoxins.
TNF is a product of stimulated monocytes and
macrophages, but it is also produced by kerati-
nocytes. In addition to the cytotoxic activities of
TNF in some types of transformed cells, recent
data have shown that TNFa mediated stimulation
of collagenase synthesis and prostaglandin E2
(PGE2) production by synovial cells,
7 and stimu-
lated bone resorption and inhibition,
8 suggesting
that TNFa might be an important mediator of
inflammation. Platelet activating factor (PAF) is a
mediator of anaphylaxis and inflammation; it
plays an important role in inflammation, and
there is cooperation between PAF and TNFa in
inflammatory reactions. It has been found that
EsA reduced release of PAF from rat macro-
phages. A previous study also showed that Esa
can inhibit the inflammatory reaction induced by
carrageenan. Recent clinical trials showed that a
Chinese herb containing EsA had a significant
curative effect on chocolate cyst. Our recent test
showed that EsA could significantly inhibit It-1
and IL-6 production from murine macrophages.
2
Thus, together with the present investigation it is
suggested that the anti-inflammatory effects of
EsA might be due to its reducing effects on the
release of TNFa, PAF, IL-1, IL-6 and other inflam-
matory mediators.
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